Ganvir Ophthalmic Gel contains Ganciclovir 0.15% w/w, an antiviral medication specifically formulated for the treatment of ocular viral infections. Ganciclovir is a synthetic nucleoside analogue that inhibits viral DNA synthesis, effectively targeting herpes simplex virus types 1 and 2, cytomegalovirus, and other herpesviruses responsible for eye infections. This gel formulation ensures prolonged contact time with the corneal surface, enhancing drug absorption and therapeutic efficacy while minimizing systemic exposure. Ganvir Ophthalmic Gel is primarily indicated for the treatment of acute herpetic keratitis, including epithelial keratitis caused by herpes simplex virus. It helps reduce viral replication, alleviates symptoms such as redness, pain, and photophobia, and promotes faster healing of corneal lesions. The gel is typically applied topically to the affected eye(s) as prescribed by a healthcare professional, usually several times a day. Patients should avoid touching the tip of the applicator to any surface to maintain sterility. Common side effects may include mild eye irritation, burning sensation, or redness, which are generally transient. Ganvir Ophthalmic Gel should be used under medical supervision, especially in individuals with known hypersensitivity to ganciclovir or other components of the formulation. Proper adherence to dosing instructions is essential for optimal outcomes.